Key result
Matrix metalloproteinases and other novel inflammatory biomarkers increasingly help evaluate adverse outcome risk in ACS.
Population
Artificially synthesized magnesium phosphate bions and calcium phosphate bions in blood-mimetic medium
Comparison
Magnesium phosphate bions (MPB) vs Calcium phosphate bions (CPB)
Design
Preclinical
Authors
Loading...
May support biomarker integration into ACS risk models; leaves open translation from animal data.
Magnesium phosphate bions are morphologically similar to calcium phosphate bions but differ in inorganic composition, making them an appropriate control group for evaluating CPB-specific endothelial toxicity.
Pecherina et al. (2019) conducted a review in Myocardial Infarction. Matrix metalloproteinases was evaluated. Matrix metalloproteinases and other novel inflammatory biomarkers are increasingly utilized to evaluate the risk of adverse outcomes in patients with acute coronary syndrome.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: